½ÃÀ庸°í¼­
»óǰÄÚµå
1596235

¼¼°èÀÇ ¸Á¸· ¿µ»óÁø´Ü ±â±â ½ÃÀå : À¯Çüº°, ÃÖÁ¾ »ç¿ëÀÚº° ¿¹Ãø(2025-2030³â)

Retinal Imaging Devices Market by Type (Fluorescein Angiography, Fundus Camera, Optical Coherence Tomography), End-User (ASCs, Hospitals, Ophthalmic Centers) - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 188 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¸Á¸· ¿µ»óÁø´Ü ±â±â(Retinal Imaging Devices) ½ÃÀåÀº 2023³â 53¾ï 9,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾úÀ¸¸ç 2024³â 57¾ï 9,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ÃßÁ¤µÇ¸ç, CAGR 7.55%·Î ¼ºÀåÇßÀ¸¸ç 2030³â¿¡´Â 89¾ï 7,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸Á¸· ¿µ»óÁø´Ü ±â±â´Â ¾È°ú ºÐ¾ß¿¡¼­ ³ì³»Àå, ´ç´¢º´¼º ¸Á¸·Áõ, Ȳ¹Ýº¯¼º°ú °°Àº ¾È°ú ÁúȯÀ» Á¶±â¿¡ Áø´ÜÇÏ°í °ü¸®ÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀÌ ¹üÀ§´Â ¾ÈÀú Ä«¸Þ¶ó, ±¤°£¼· ´ÜÃþ ÃÔ¿µ ½ºÄ³³Ê, Ç÷ç¿À·¹¼¼ÀÎ Ç÷°ü Á¶¿µ ÀåÄ¡¸¦ Æ÷ÇÔÇÑ ´Ù¾çÇÑ Á¦Ç°À» Æ÷ÇÔÇÕ´Ï´Ù. ³ëÀÎ Àα¸ Áõ°¡, ¸¸¼º ¾È°ú ÁúȯÀÇ À¯º´·ü Áõ°¡, ±â¼ú ¹ßÀüÀº º´¿ø, Ŭ¸®´Ð, ¿¬±¸ ȯ°æ¿¡¼­ Á¡Á¡ ´õ ¸¹ÀÌ Àû¿ëµÇ°í ÀÖ´Â ÀÌ·¯ÇÑ ÀåÄ¡ÀÇ Çʿ伺À» °­Á¶ÇÕ´Ï´Ù. ´« °Ç°­¿¡ ´ëÇÑ ÀÎ½Ä Á¦°í, ´õ ³ªÀº ÀÇ·á ÀÎÇÁ¶ó, ºñħ½ÀÀûÀ̰í Á¤¹ÐÇÑ Áø´Ü µµ±¸¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ ½ÃÀåÀº »ó´çÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±×·¯³ª °í±Þ ¿µ»ó ½Ã½ºÅÛÀÇ ³ôÀº ºñ¿ë, Àú¼Òµæ Áö¿ª¿¡¼­ÀÇ Á¢±Ù Á¦ÇÑ, ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼÷·ÃµÈ Àη ºÎÁ·°ú °°Àº ¹®Á¦´Â ½ÃÀå È®ÀåÀ» ¹æÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÁÖ¿ä ¼ºÀå ¿äÀÎÀ¸·Î´Â ½Ã·Â °ü¸®¸¦ À§ÇÑ Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê, Áø´Ü Á¤È®µµ Çâ»óÀ» À§ÇÑ Àΰø Áö´É ¹× µö ·¯´×ÀÇ ÅëÇÕ, ÈÞ´ë¿ë ¹× ȯÀÚ Ä£È­ÀûÀÎ ÀåÄ¡ÀÇ Áö¼ÓÀûÀÎ Çõ½Å µîÀÌ ÀÖ½À´Ï´Ù. ¸Á¸· ¿µ»ó ¿µ¿ªÀÇ Ç÷¹À̾î´Â AI ±â¹Ý Áø´Ü, ºñ¿ë È¿À²ÀûÀÎ Á¦Ç° °³¹ß, ¹Ì°³Ã´ ½ÃÀå ÁøÃâ È®´ë¸¦ À§ÇÑ Ç¥Àû Àü·«À» À§ÇÑ Çù¾÷¿¡ ÁýÁßÇÒ °ÍÀ» ±ÇÀåÇÕ´Ï´Ù. ƯÈ÷ ¿ø°Ý ÀÇ·á, ¿ø°Ý ÀÇ·á, ȯÀÚ °á°ú °³¼±À» À§ÇÑ ºò µ¥ÀÌÅÍ ºÐ¼® Ȱ¿ë¿¡ »õ·Î¿î ±âȸ°¡ ÀÖ½À´Ï´Ù. ¿þ¾î·¯ºí ¸Á¸· ½ºÄ³³Ê ¹× Áõ°­ Çö½Ç ¾ÖÇø®ÄÉÀ̼ÇÀ» Æ÷ÇÔÇÏ¿© ´õ ½º¸¶Æ®ÇÏ°í ´õ ºü¸£°í »ç¿ëÀÚ Ä£È­ÀûÀÎ ÀåÄ¡¸¦ °³¹ßÇÒ ¼ö ÀÖ´Â ÀáÀç·ÂÀ¸·Î Çõ½Å ȯ°æÀÌ ¹«¸£ÀͰí ÀÖ½À´Ï´Ù. À¯¸ÁÇÑ Àü¸Á¿¡µµ ºÒ±¸ÇÏ°í ±â¾÷µéÀº ½ÃÀå ħÅõ¿Í ¼ºÀåÀ» º¸ÀåÇϱâ À§ÇØ ±ÔÁ¦ º¹À⼺À» Ž»öÇϰí ȯ±Þ ¹®Á¦¸¦ ÇØ°áÇÏ¸ç °æÀï·Â ÀÖ´Â °¡°ÝÀ» À¯ÁöÇØ¾ß ÇÕ´Ï´Ù. Àü¹ÝÀûÀ¸·Î ¸Á¸· ¿µ»óÁø´Ü ±â±â ½ÃÀåÀº ¿ªµ¿ÀûÀ̸ç, ÁøÈ­ÇÏ´Â ±â¼úÀº ¾È°ú ÀÇ·á ¼­ºñ½º Á¦°ø°ú ±Û·Î¹ú ½Ã·Â °Ç°­ °á°ú °³¼±¿¡ »ó´çÇÑ ÀáÀç·ÂÀ» Á¦½ÃÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ¿¬µµ(2023³â) 53¾ï 9,000¸¸ ´Þ·¯
ÃßÁ¤¿¬µµ(2024³â) 57¾ï 9,000¸¸ ´Þ·¯
¿¹Ãø¿¬µµ(2030³â) 89¾ï 7,000¸¸ ´Þ·¯
CAGR(%) 7.55%

½ÃÀå ¿ªÇÐ : ±Þ¼ÓÈ÷ ÁøÈ­ÇÏ´Â ¸Á¸· ¿µ»óÁø´Ü ±â±â ½ÃÀåÀÇ ÁÖ¿ä ÀλçÀÌÆ® °ø°³

¸Á¸· ¿µ»óÁø´Ü ±â±â ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖÀ¸¸ç, ÀÌ¿¡ µû¶ó »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦ÀûÀÎ ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ½°ú µ¿½Ã¿¡ ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¶Ç´Â ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ»º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¾È°ú ÁúȯÀÇ ÀÌȯÀ²°ú Áõ·Ê Áõ°¡
    • Àü·«Àû ÀÌ´Ï¼ÅÆ¼ºê Áõ°¡
    • À̹ÌÁö ¸ð´Þ¸®Æ¼¿Í ÀΰøÁö´ÉÀÇ ÅëÇÕ ¹× ÈÞ´ë±â±â °³¹ß
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ¾ÈÀú Ä«¸Þ¶ó, ±¤°£¼· ´ÜÃþ°è(OCT)ÀÇ °íºñ¿ë
  • ½ÃÀå ±âȸ
    • ÷´Ü ¸Á¸· À̹ÌÁö ¼Ö·ç¼Ç Ãâ½Ã·Î °³¹ß Áõ°¡
    • ½ÅÈï±¹¿¡¼­ ÇコÄɾî Áõ°¡
  • ½ÃÀå °úÁ¦
    • Á¦Ç° ¸®ÄÝ Áõ°¡

Porter's Five Forces : ¸Á¸· ¿µ»óÁø´Ü ±â±â ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ºñÁî´Ï½º Á¶Á÷ÀÌ °æÀïÀû À§Ä¡¸¦ Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ý·ÐÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ÈûÀÇ ¿ªÇÐ °ü°è¸¦ Æò°¡ÇÏ°í »õ·Î¿î º¥Ã³ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °­Á¡À» Ȱ¿ëÇÏ°í ¾àÁ¡À» ÇØ°áÇϸç ÀáÀçÀûÀÎ ¹®Á¦¸¦ ¹æÁöÇÏ¿© º¸´Ù ź·ÂÀûÀÎ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ¸Á¸· ¿µ»óÁø´Ü ±â±â ½ÃÀå¿¡¼­ ¿ÜºÎ ¿µÇâÀ» ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ¸Á¸· ¿µ»óÁø´Ü ±â±â ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡, °æÁ¦, »çȸ, ±â¼ú, ¹ý·ü ¹× ȯ°æ ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ¿© ¼±Á¦ÀûÀÌ°í ¹Ì·¡ ÁöÇâÀûÀÎ ÀÇ»ç °áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ¸Á¸· ¿µ»óÁø´Ü ±â±â ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

¸Á¸· ¿µ»óÁø´Ü ±â±â ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¸ÅÃâ, °í°´ ±â¹Ý, ¼ºÀå·ü µîÀÇ ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï ¿ìÀ§¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀå ÁýÁßµµ, ¼¼ºÐÈ­, ÅëÇÕ Ãß¼¼¸¦ °­Á¶ÇÏ¿© º¥´õ°¡ °æÀïÀÌ Ä¡¿­ÇØÁö´Â ȯ°æ¿¡¼­ ÀÔÁö¸¦ °­È­ÇÏ´Â Àü·«Àû °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ¸Á¸· ¿µ»óÁø´Ü ±â±â ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ¸Á¸· ¿µ»óÁø´Ü ±â±â ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î º¥´õ¸¦ Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. 4°³ÀÇ »çºÐ¸éÀº °ø±Þ¾÷ü¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© »ç¿ëÀÚ°¡ Àü·«Àû ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ : ¸Á¸· ¿µ»óÁø´Ü ±â±â ½ÃÀå¿¡¼­ ¼º°øÀ» À§ÇÑ ±æÀ» ±×¸®±â

¸Á¸· ¿µ»óÁø´Ü ±â±â ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ±Û·Î¹ú ½ÃÀå¿¡¼­ ÀÔÁö °­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÀÌ Á¢±Ù¹ýÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖ´Â ½Ã½ºÅÛÀ» ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·ÂÀ» Æò°¡ÇÕ´Ï´Ù.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ÇâÈÄ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ ¹× ±ÔÁ¦ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ¡¤Ã¶¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø ¹× Àü·«Àû ±âȸ´Â?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ¾È°ú ÁúȯÀÇ ¹ß»ý·ü°ú Áõ·Ê Áõ°¡
      • Àü·«Àû ³ë·Â Áõ°¡
      • ¿µ»ó ó¸® ±â¼ú°ú ÀΰøÁö´ÉÀÇ ÅëÇÕ°ú ÈÞ´ë¿ë µð¹ÙÀ̽ºÀÇ °³¹ß
    • ¾ïÁ¦¿äÀÎ
      • ¾ÈÀú Ä«¸Þ¶ó¿Í ±¤°£¼· ´ÜÃþÃÔ¿µ(OCT)ÀÇ °íºñ¿ë
    • ±âȸ
      • ÷´Ü ¸Á¸· À̹ÌÁö ¼Ö·ç¼Ç Ãâ½Ã¸¦ À§ÇÑ °³¹ß È®´ë
      • ½ÅÈï±¹¿¡¼­ ÀÇ·á ÇコÄɾîÀÇ Çâ»ó
    • °úÁ¦
      • Á¦Ç° ¸®ÄÝ Áõ°¡
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦Àû
    • »çȸÀû
    • ±â¼úÀû
    • ¹ýÀû
    • ȯ°æÀû

Á¦6Àå ¸Á¸· ¿µ»óÁø´Ü ±â±â ½ÃÀå : À¯Çüº°

  • Ç÷ç¿À·¹¼¼ÀÎ Ç÷°ü Á¶¿µ¼ú
  • ¾ÈÀú Ä«¸Þ¶ó
  • ±¤ °£¼· ´ÜÃþ ÃÔ¿µ

Á¦7Àå ¸Á¸· ¿µ»óÁø´Ü ±â±â ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ASCs
  • º´¿ø
  • ¾È°ú ¼¾ÅÍ

Á¦8Àå ¾Æ¸Þ¸®Ä«ÀÇ ¸Á¸· ¿µ»óÁø´Ü ±â±â ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦9Àå ¾Æ½Ã¾Æ ÅÂÆò¾çÀÇ ¸Á¸· ¿µ»óÁø´Ü ±â±â ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦10Àå À¯·´¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¸Á¸· ¿µ»óÁø´Ü ±â±â ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦11Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼® ¹× Ãßõ

±â¾÷ ¸ñ·Ï

  • Avinger, Inc
  • Basler AG
  • BaySpec, Inc.
  • Epipole Ltd.
  • Excelitas Technologies Corp.
  • Eyenuk, Inc.
  • Forus Health Pvt Ltd,
  • Hill-Rom Holdings, Inc.
  • Imagine Eyes
  • Nidek Co., Ltd.
  • Olympus Corporation
  • Optomed PLC
  • Optos PLC
  • Robert Bosch GmbH
  • Thorlabs, Inc
LYJ

The Retinal Imaging Devices Market was valued at USD 5.39 billion in 2023, expected to reach USD 5.79 billion in 2024, and is projected to grow at a CAGR of 7.55%, to USD 8.97 billion by 2030.

Retinal imaging devices play a crucial role in ophthalmology, enabling early diagnosis and management of eye diseases such as glaucoma, diabetic retinopathy, and macular degeneration. The scope encompasses a range of products including fundus cameras, optical coherence tomography scanners, and fluorescein angiography devices. The growing geriatric population, rising prevalence of chronic eye conditions, and technological advancements underscore the necessity of these devices, which are increasingly applied in hospitals, clinics, and research settings. The market is poised for significant growth due to heightened awareness of eye health, better healthcare infrastructure, and increasing demand for non-invasive and precise diagnostic tools. However, challenges such as high costs of advanced imaging systems, limited access in low-income regions, and lack of trained personnel in emerging markets could hinder market expansion. Key growth factors include government initiatives for vision care, integration of Artificial Intelligence and deep learning to enhance diagnostic accuracy, and ongoing innovations in portable and patient-friendly devices. Players in the retinal imaging domain are advised to focus on collaborations for AI-driven diagnostics, cost-effective product development, and targeted strategies to expand reach in untapped markets. Emerging opportunities lie in telemedicine, particularly in enhancing eye care in remote areas, and in leveraging big data analytics to improve patient outcomes. The innovation landscape is ripe with potential for developing smarter, faster, and more user-friendly devices, including wearable retinal scanners and augmented reality applications. Despite the promising outlook, companies must navigate regulatory complexities, address reimbursement issues, and maintain competitive pricing to ensure market penetration and growth. Overall, the retinal imaging devices market is dynamic, with evolving technologies presenting substantial potential for advancements in eye healthcare delivery and improved global vision health outcomes.

KEY MARKET STATISTICS
Base Year [2023] USD 5.39 billion
Estimated Year [2024] USD 5.79 billion
Forecast Year [2030] USD 8.97 billion
CAGR (%) 7.55%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Retinal Imaging Devices Market

The Retinal Imaging Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing incidence and cases of ophthalmic diseases
    • Increasing volume of strategic initiatives
    • Integration of imaging modalities with artificial intelligence and the development of portable devices
  • Market Restraints
    • High cost of Fundus Camera, and Optical Coherence Tomography (OCT)
  • Market Opportunities
    • Increasing development of launching advanced retinal imaging solutions
    • Increasing medical healthcare in emerging economies
  • Market Challenges
    • Increasing number of product recalls

Porter's Five Forces: A Strategic Tool for Navigating the Retinal Imaging Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Retinal Imaging Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Retinal Imaging Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Retinal Imaging Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Retinal Imaging Devices Market

A detailed market share analysis in the Retinal Imaging Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Retinal Imaging Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Retinal Imaging Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Retinal Imaging Devices Market

A strategic analysis of the Retinal Imaging Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Retinal Imaging Devices Market, highlighting leading vendors and their innovative profiles. These include Avinger, Inc, Basler AG, BaySpec, Inc., Epipole Ltd., Excelitas Technologies Corp., Eyenuk, Inc., Forus Health Pvt Ltd,, Hill-Rom Holdings, Inc., Imagine Eyes, Nidek Co., Ltd., Olympus Corporation, Optomed PLC, Optos PLC, Robert Bosch GmbH, and Thorlabs, Inc.

Market Segmentation & Coverage

This research report categorizes the Retinal Imaging Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Fluorescein Angiography, Fundus Camera, and Optical Coherence Tomography.
  • Based on End-User, market is studied across ASCs, Hospitals, and Ophthalmic Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidence and cases of ophthalmic diseases
      • 5.1.1.2. Increasing volume of strategic initiatives
      • 5.1.1.3. Integration of imaging modalities with artificial intelligence and the development of portable devices
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of Fundus Camera, and Optical Coherence Tomography (OCT)
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing development of launching advanced retinal imaging solutions
      • 5.1.3.2. Increasing medical healthcare in emerging economies
    • 5.1.4. Challenges
      • 5.1.4.1. Increasing number of product recalls
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Retinal Imaging Devices Market, by Type

  • 6.1. Introduction
  • 6.2. Fluorescein Angiography
  • 6.3. Fundus Camera
  • 6.4. Optical Coherence Tomography

7. Retinal Imaging Devices Market, by End-User

  • 7.1. Introduction
  • 7.2. ASCs
  • 7.3. Hospitals
  • 7.4. Ophthalmic Centers

8. Americas Retinal Imaging Devices Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Retinal Imaging Devices Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Retinal Imaging Devices Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Avinger, Inc
  • 2. Basler AG
  • 3. BaySpec, Inc.
  • 4. Epipole Ltd.
  • 5. Excelitas Technologies Corp.
  • 6. Eyenuk, Inc.
  • 7. Forus Health Pvt Ltd,
  • 8. Hill-Rom Holdings, Inc.
  • 9. Imagine Eyes
  • 10. Nidek Co., Ltd.
  • 11. Olympus Corporation
  • 12. Optomed PLC
  • 13. Optos PLC
  • 14. Robert Bosch GmbH
  • 15. Thorlabs, Inc
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦